[Clinical study of the antineoplastic effect of DL-p-bis(beta-chloroethyl) aminophenylalanine].
D000818:Animals; D000970:Antineoplastic Agents; D006801:Humans; D008198:Lymph Nodes; D016403:Lymphoma, Large B-Cell, Diffuse / Q000628:therapy*; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy*; D008466:Mechlorethamine; D009369:Neoplasms; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use*; D010649:Phenylalanine / Q000031:analogs & derivatives; D012509:Sarcoma
D000970:Antineoplastic Agents; D009588:Nitrogen Mustard Compounds; D010649:Phenylalanine; D008466:Mechlorethamine
LYMPH NODES/neoplasms; NITROGEN MUSTARDS/therapeutic use; PHENYLALANINE/related compounds; SARCOMA, RETICULUM CELL/therapy
Studio clinico dell'attività antineoplastica della DL-p-bis (beta-cloroetil) aminofenilalanina; nota preventiva.